The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 17,021 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 23,498 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 11,204 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 19,916 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 20,762 | 298,000 | SH | SOLE | 298,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 10,506 | 127,500 | SH | SOLE | 127,500 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 9,809 | 1,475,000 | SH | SOLE | 1,475,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 3,225 | 177,500 | SH | SOLE | 177,500 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 3,201 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
| EVOLENT HEALTH INC | CL A | 30050B101 | 14,151 | 795,000 | SH | SOLE | 795,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 2,178 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 19,296 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 14,445 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 11,799 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 8,765 | 44,000 | SH | SOLE | 44,000 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 6,229 | 399,825 | SH | SOLE | 399,825 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 19,060 | 106,000 | SH | SOLE | 106,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 33,163 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 23,996 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 1,778 | 207,500 | SH | SOLE | 207,500 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 14,952 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 21,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 18,677 | 209,474 | SH | SOLE | 209,474 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 3,771 | 256,215 | SH | SOLE | 256,215 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 4,970 | 38,500 | SH | SOLE | 38,500 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 16,781 | 815,000 | SH | SOLE | 815,000 | 0 | 0 | ||